Bespoke plant glycoconjugates for gut microbiota–mediated drug targeting
Science · 2025
DOI: 10.1126/science.adk7633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2025. Verfasst von Wei Jen Ma und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Drug Delivery Systems, Gastrointestinal Microbiome, Glycoconjugates. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
The gut microbiota of mammals possess distinctive metabolic pathways with untapped therapeutic potential. Using molecular insights into dietary fiber metabolism by the human gut microbiota, we designed a targeted drug delivery system, called GlycoCaging, that is based on bespoke glycoconjugates of a complex plant oligosaccharide. GlycoCaging of exemplar anti-inflammatory drugs enabled release of active molecules triggered by specific glycosidases of autochthonous gut bacteria. GlycoCaging ensured that drug efficacy was potentiated, and off-target effects were eliminated in murine models of inflammatory bowel disease. Biochemical and metagenomic analyses of gut microbiota of individual humans confirmed the broad applicability of this strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
- Michael Smith Laboratories and Department of Chemistry, University of British Columbia, Vancouver, BC, Canada.
- Lethbridge Research and Development Centre, Agriculture and Agri-Food Canada, Lethbridge, AB, Canada.
- Department of Biology, University of British Columbia-Okanagan Campus, Kelowna, BC, Canada.
- Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, USA.
ORCID-Profile: Wei Jen Ma, Changqing Wang, Jagatheeswaran Kothandapani, Susan C Menzies, Alexander S C Fraser, Kathaleen E House, Paul E Moote, Xiaohui Xing, Benjamin Wei-Qiang Hui, Sandra T Clarke, Natasha Haskey, Deanna L Gibson, Eric C Martens, D Wade Abbott, G Douglas Inglis, Laura M Sly, Harry Brumer
Zitieren
APA
Ma, W. J., Wang, C., Kothandapani, J., Luzentales-Simpson, M., Menzies, S. C., Bescucci, D. M., Lange, M. E., Fraser, A. S. C., Gusse, J. F., House, K. E., Moote, P. E., Xing, X., Grondin, J. M., Hui, B. W., Clarke, S. T., Shelton, T. G., Haskey, N., Gibson, D. L., Martens, E. C., …, & Brumer, H. (2025). Bespoke plant glycoconjugates for gut microbiota–mediated drug targeting. Science. https://doi.org/10.1126/science.adk7633
Vancouver
Ma WJ, Wang C, Kothandapani J, Luzentales-Simpson M, Menzies SC, Bescucci DM, et al. Bespoke plant glycoconjugates for gut microbiota–mediated drug targeting. Science. 2025. doi:10.1126/science.adk7633
BibTeX
@article{Ma2025,
author = {Ma, Wei Jen and Wang, Changqing and Kothandapani, Jagatheeswaran and Luzentales-Simpson, Matthew and Menzies, Susan C and Bescucci, Danisa M and Lange, Máximo E and Fraser, Alexander S C and Gusse, Jenny F and House, Kathaleen E and Moote, Paul E and Xing, Xiaohui and Grondin, Julie M and Hui, Benjamin Wei-Qiang and Clarke, Sandra T and Shelton, Tara G and Haskey, Natasha and Gibson, Deanna L and Martens, Eric C and Abbott, D Wade and Inglis, G Douglas and Sly, Laura M and Brumer, Harry},
title = {Bespoke plant glycoconjugates for gut microbiota–mediated drug targeting},
journal = {Science},
year = {2025},
doi = {10.1126/science.adk7633}
}
EUVIMED